Workers in the pharmaceutical industry may be exposed to many potential carcinogens.
We investigated cancer morbidity in a Danish plant where enzymes, insulin, antibiotics and sex hormones were produced in substantial quantities.
Altogether 10 889 people ever employed (1964-1988) at the pharmaceutical plant were retrieved from the files of a compulsory pension fund, and followed-up in the nationwide Danish Cancer Registry (1964-1989).
Site-specific standardized incidence ratios (SIR) were estimated, based on cancer rates for the national population.
Mots-clés Pascal : Tumeur maligne, Morbidité, Exposition professionnelle, Carcinogène, Homme, Toxicité, Danemark, Europe, Industrie pharmaceutique, Epidémiologie
Mots-clés Pascal anglais : Malignant tumor, Morbidity, Occupational exposure, Carcinogen, Human, Toxicity, Denmark, Europe, Pharmaceutical industry, Epidemiology
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 94-0714616
Code Inist : 002B04B. Création : 09/06/1995.